Annual EBITDA
$337.93M$32.58M+10.67%
Summary
- Current Value
- As of today, HAE annual EBITDA is $337.93M, up +10.67% on
- Historical Performance
- HAE annual EBITDA is up +61.69% over the past 3 years, and up +10.68% over the past 5 years
- All-Time High Comparison
- HAE annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- HAE annual EBITDA is +61.69% above its 3-year low of $209.00M reached on an earlier date
- Sector Comparison
- HAE annual EBITDA is higher than 89.75% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $337.93M | +10.7% | +61.7% | +10.7% | +104.9% | |
| Quarterly EBITDA | $95.53M | +11.5% | +36.6% | +80.9% | +139.1% | |
| TTM EBITDA | $350.67M | +11.2% | +48.0% | +53.0% | +106.7% | |
| Price | $82.77 | +5.0% | +12.5% | -33.2% | +181.5% | |
| PE Ratio | 24.15 | -22.1% | -38.9% | -58.9% | +1.4% | |
| Annual Revenue | $1.36B | +4.0% | +37.0% | +37.7% | +110.6% | |
| Annual EPS | $3.31 | +44.5% | +291.4% | +123.8% | +195.1% | |
| Annual EBIT | $222.34M | +6.8% | +99.9% | +14.0% | +82.7% | |
| Annual Net Income | $167.68M | +42.6% | +286.6% | +119.1% | +187.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $337.93M | at high | |
| 5Y | $337.93M | at high | |
| All | $337.93M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $209.00M | N/A | +61.7% |
| 5Y | $178.81M | +89.0% | |
| All | $30.83M | +996.0% |
EBITDA History
FAQ
What is the current annual EBITDA of HAE?
As of today, HAE annual EBITDA is $337.93M
What is 1-year change in HAE annual EBITDA?
HAE annual EBITDA is up +10.67% year-over-year
What is 3-year change in HAE annual EBITDA?
HAE annual EBITDA is up +61.69% over the past 3 years
How far is HAE annual EBITDA from its all-time high?
HAE annual EBITDA is currently at its all-time high
How does HAE annual EBITDA rank versus sector peers?
HAE annual EBITDA is higher than 89.75% of companies in Healthcare sector
When is HAE next annual earnings release?
As of today, the next annual earnings release for HAE has not been scheduled
Quarterly EBITDA
$95.53M$11.64M+13.87%
Summary
- Current Value
- As of today, HAE quarterly EBITDA is $95.53M, up +13.87% on
- Historical Performance
- HAE quarterly EBITDA is up +11.47% year-over-year, and up +36.57% over the past 3 years
- All-Time High Comparison
- HAE quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- HAE quarterly EBITDA is +42.82% above its 3-year low of $66.89M reached on an earlier date
- Sector Comparison
- HAE quarterly EBITDA is higher than 88.63% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $95.53M | +13.9% | +11.5% | +36.6% | +80.9% | |
| Annual EBITDA | $337.93M | – | +10.7% | +61.7% | +10.7% | |
| TTM EBITDA | $350.67M | +2.9% | +11.2% | +48.0% | +53.0% | |
| Price | $82.77 | +67.0% | +5.0% | +12.5% | -33.2% | |
| PE Ratio | 24.15 | +67.0% | -22.1% | -38.9% | -58.9% | |
| Quarterly Revenue | $327.32M | +1.8% | -5.3% | +10.0% | +56.3% | |
| Quarterly EPS | $0.81 | +15.3% | +22.9% | +26.0% | -13.8% | |
| Quarterly EBIT | $67.28M | +22.0% | +19.1% | +44.6% | +110.8% | |
| Quarterly Net Income | $38.68M | +13.7% | +14.3% | +16.5% | -19.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $95.53M | at high | |
| 3Y | $95.53M | at high | |
| 5Y | $95.53M | at high | |
| All | $95.53M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $79.67M | +19.9% | |
| 3Y | $66.89M | N/A | +42.8% |
| 5Y | $20.44M | +367.4% | |
| All | $6.55M | +1359.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of HAE?
As of today, HAE quarterly EBITDA is $95.53M
What is HAE quarterly EBITDA most recent change?
HAE quarterly EBITDA was up +13.87% on September 27, 2025
What is 1-year change in HAE quarterly EBITDA?
HAE quarterly EBITDA is up +11.47% year-over-year
How far is HAE quarterly EBITDA from its all-time high?
HAE quarterly EBITDA is currently at its all-time high
How does HAE quarterly EBITDA rank versus sector peers?
HAE quarterly EBITDA is higher than 88.63% of companies in Healthcare sector
When is HAE next earnings release?
The next earnings release for HAE is on
TTM EBITDA
$350.67M$9.83M+2.88%
Summary
- Current Value
- As of today, HAE TTM EBITDA is $350.67M, up +2.88% on
- Historical Performance
- HAE TTM EBITDA is up +11.15% year-over-year, and up +48.00% over the past 3 years
- All-Time High Comparison
- HAE TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- HAE TTM EBITDA is +44.31% above its 3-year low of $243.00M reached on an earlier date
- Sector Comparison
- HAE TTM EBITDA is higher than 88.63% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $350.67M | +2.9% | +11.2% | +48.0% | +53.0% | |
| Annual EBITDA | $337.93M | – | +10.7% | +61.7% | +10.7% | |
| Quarterly EBITDA | $95.53M | +13.9% | +11.5% | +36.6% | +80.9% | |
| Price | $82.77 | +67.0% | +5.0% | +12.5% | -33.2% | |
| PE Ratio | 24.15 | +67.0% | -22.1% | -38.9% | -58.9% | |
| TTM Revenue | $1.33B | -1.4% | -2.5% | +22.5% | +47.1% | |
| TTM EPS | $3.43 | +4.6% | +42.4% | +105.2% | +65.6% | |
| TTM EBIT | $236.43M | +4.8% | +14.8% | +66.6% | +79.5% | |
| TTM Net Income | $168.19M | +3.0% | +35.8% | +95.5% | +58.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $350.67M | at high | |
| 3Y | $350.67M | at high | |
| 5Y | $350.67M | at high | |
| All | $350.67M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $329.59M | N/A | +6.4% |
| 3Y | $243.00M | N/A | +44.3% |
| 5Y | $165.37M | +112.0% | |
| All | $36.80M | +852.9% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of HAE?
As of today, HAE TTM EBITDA is $350.67M
What is HAE TTM EBITDA most recent change?
HAE TTM EBITDA was up +2.88% on September 27, 2025
What is 1-year change in HAE TTM EBITDA?
HAE TTM EBITDA is up +11.15% year-over-year
How far is HAE TTM EBITDA from its all-time high?
HAE TTM EBITDA is currently at its all-time high
How does HAE TTM EBITDA rank versus sector peers?
HAE TTM EBITDA is higher than 88.63% of companies in Healthcare sector
When is HAE next earnings release?
The next earnings release for HAE is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- HAE Official Website www.haemonetics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/313143/000031314325000075/0000313143-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/313143/000031314325000025/0000313143-25-000025-index.htm
- HAE Profile on Yahoo Finance finance.yahoo.com/quote/HAE
- HAE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hae